This brand name is authorized in Malta, Netherlands, South Africa
The drug REGITINE contains one active pharmaceutical ingredient (API):
|
1
Phentolamine mesylate
UNII Y7543E5K9T - PHENTOLAMINE MESYLATE
|
|
Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C04AB01 | Phentolamine | C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AB Imidazoline derivatives |
| V03AB36 | Phentolamine | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): AA565/63302 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 12144371 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 221 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): C/5.2/749 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
